Anna Almén-Christensson

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The effect of treatment with percutaneous E(2) (100 μg/24 h) during 2 weeks perimenstrually on the number and severity of menstrual migraine attacks was studied in 27 women in a randomized, placebo-controlled, double-blind, crossover trial. We were not able to demonstrate any difference between E(2) supplementation and placebo on the number or severity of(More)
  • 1